Anda di halaman 1dari 4

Krebs Biochemicals & lndustries Limited

Cf N : 124110AP!.99lP1C1O39L2

thFebruary 2017

To, To,
The Manager, The Manager,
Department of Corporate Relations, Listing Departrnent,
BSE Limited, National Stock Exchange of India Ltd.,
P J Towers, Dalal Street, Exchange Plaza, BandraKurla Complex,
Fort, Mumbai- 400001. Bandra (E), Mumbai- 40005 1.

Dear Sir/Madam,

Sub: Outcome of Board Meeting held on gfrFebntary 2017 '

Board of
We refer to the above mentioned subject, we herewith intimate the Exchange, and that the
Directors at their meeting held on 9ft February 2017 has considered and approved interalia the
following items of business:

31't December
1. Unaudited Financial results and the Limited Review Report for the quarter ended
2016. enclosed herewith.

This is for the information and records of the Exchange, Please'

Kindly note that the board meeting commenced at 01:00 PM and concluded at 4:30 PM

Thanking You,

Yours Fai
For Industries Limited
:b

Company

Encl. As above

Regd. Office : Kothapalli (V), Kasimkota (M), Anakapalli, Visakhapatnam, Andhra Pradesh-53103L
Corporate Office : 8-2-57718, Plot No. 34,3rd Floor, Maas Heights, Road No.8, Banjara Hills, Hyderabad-SOO 034
Tel :040-66808040 E-mail : marketing@krebsbiochem.com Website : www.krebsbiochem.com
KREBS BIOCHEMICALS & INDUSTRIES LIMITED
CIN:L241 l0APr99lPLCr03912
Registered Office: Kothapalli Village, Kasimkota Mandal, Anakapalli, Visakhapatnam, Andhra Pradesb - 531 031
No:8, Banjara Hills, Hyderabad - 500 034
STAND ALONE FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED 3IST DECEMBER 2016
(Rs. In

Prevlous Year
Quarter Ended Nine Months Ended
Endcd
Particulars
31,12.2016 30.09.2016 31.12.2015 31.12.2016 31.12.201 5 3t.03.20 | 6
(Unaudited (Uneudited) fllnaudite.ll T (Unaudited) {tlnnudiledl
PART. I
I lncome from Onerations
t) Net Sales / Income from ODerations 145 8s8 r1_19 t7 79
r) Other Operatins Income 39 00 39 00 516 117 00 84_ t6 23.17
fotal Income from oDerations (net) 40.45 39.00 45.16 125.58 l0l- 95 llo,96
2 Expenses
Cost of Material Consumed 0.03 069 18 48) 0.83 175_ 64 7'1 26
b. Changes in inventories offinished goods,
work-in-orogess and stock -in-trade
t47 (6 39 18.85 (0.85) (221 s8) (162.69
Employee benefits expense 141.88 149.36 120.83 4 15.18 368- 44 566.52
Depreciation and Amortisation exoense t04 09 104 09 95 54 312 28 286-62 448.62
e. Other Manufacturins Exoenses 91.23 65 41 2.70 227 93 356.66 449 13
f OtherExDenses 68 99 80.88 65.21 206 46 241.'75 350.97
Iotal ExDenses 407,69 394.O4 374.6s 1.161.82 t,201- t3 1.829.8r
Profit / (Loss) from Operatiotrs before other income, finance costs and
3 (367.24) (3ss.04' (329.49\ (1.036.24) (1,(D9.18) (1,688.8s)
exceDtional items (1 - 2l
J0rer Income 370 175 263 6.s8 71-48 t02.94
5 Profit / (Loss) from ordinary activities before finance costs (3 + 4) (363.s4) (3sJ.29. (326.86) (1,029.6s) (r,027.70) (1,s8s.9t)
6 iinalce Costs 87.3s 69.70 20 90 207.72 25- 17 73 88
Profit / (Loss) from Ordinary Activities after Finance Costs but
7 (4s0.89) (422.99] (347.76) (r,237.37' (1,0s2.a7) (r,6s9.79)
before exceotional items (5 + 6)
8 Exceptional Items:
a) Debit balances wriften off (0 e3)
b) Diminition in Value of Inventory (4.04' (1.88. (14 29) n2693 (126.93
c) Amounts Written Back 4.33 t4l 19 56 574 89.66 96 49
d) Profit on Sale of Food Division's Imovable Assets 59.12 59 12
e) Prior period Income 7.46 7.46
f) Prior period Expenditure (1.00) (1.00
9 Profit / (Loss) from ordinarv activities before Tax (7 + 8) (451.60) /415.99) (328.20',1 (1.239.4s) fl.031.02) (r.632.O4
l0 Iax Expense
ll Nt Profit / (Loss) after Tax (9 + l0) (4sr.60) (4rs.9e) (328.20) (1,23e.4s) (1,031.o2) (r,632.04)
t2 Extra Ordinary Items
l3 \et Profit / (Loss) for tbe Deriod (11 + 12 (4sr.60) (415.991 (328.20r (r.239.4s) (1.031.02) (r.632.04)
t4 )tber Comprehensive Income
fotal Comprehensive Income after Tax(13 + 14)
l5 'Comprising Prolit (Loss) and
other Comprehensive Income for the (4sr.601 (4rs.e9) (328.20) (r,239.4s) (r,mr.()2) (r,6J2.04)
reriod)
l6 Paid-up Equitv Share CaDital (Tace Value Rs. 10/- eech) 1374 4: 1.374.43 1.306 43 t374 4 I,306.43 1.306 43
Resene Excluding Revaluation Reserves as per Balance Sheet of
l7 (372.26
orevious Accountins Year
Earning Per Share (before extraordinary Items) (of Rs.10/- each) (not
18 (r)
Annualised)
a) Basic 1 ?ql (3.03 (2 511 (9.02) (7 A9)
'b) Diluted
03 24
(3 29', 3.03 25ll (9 1 (7.89) (12 s4
Earnitrg Per Share (after extraordina ry Items) (of Rs. 10/- each) (not
(il,
Annuelised)
la) Basic (3.29 303 2.51) (9.U2 (7 89) (13.24
lb) Diluted (3 29 3 03)l (2.5r\ (9.11 (7.89) 02.54
The above results have been reviewed by the Audit Committee at its meeting held on 09th February, 2017 and, approved by the Board of Directors of the ComDanv at itl
meeting held on 09th February, 2017. The results were subjected to limited review by Statutory Auditors.
2 fhe Company is operating in one segrnent only hence no segment results have been disclosed.
3 iigures have been regrouped, rearranged wherever necessary

The Company has adopted Ind-As with effect from lst April 2016 with comparitives being restated. Accordingly the impact oftransition has been provided in the Openin6
reserues as at lst April 2015 and all the periods presented have been restated accordingly

Results for the quarter / nine months ended 3 1 st December 20 1 6 are in compliance with Indian Accounting Standards (Ind-As) notified by the Ministry of Corporate Affairs
5
)omply with Ind-As to make them comparable.

1.\
i-. \

(, [MffIN
ryb1h
l::
;i
'

:\.J
Place yderabad \ \\ Vvina.sh R ',. ',j
DaIe : O9.02.2017 \
KREBS BIOCHEMICALS & INDUSTRIES LIMITED
RECONCIIATION OF PROFIT AND RESERVE BETWEEN INDAS AND PREVIOUS INDIAN GAAP FOR EARLIER PERIOD
AND AS AT MARCH 37,2016

Rs.in lakhs
Reserve
Profit reconciliation reconciliation

Nine
Quarter Months Year ended
Note endad ?l andar{ 11 31st March As at 31st
sl # Nature of adiustments ref. Dec 2015 Dec 2015 20L6 March 2016
Net Profit / Reserves as per Previous Indian
GAAP (328.201 (1,031.02) (1,632.041 (.L,477.971
Fair valuation as deemed cost for Property, Plant
1 and Equipment 1 4,743.25
2 Fair valuation of Intangible Assets 2 (37s.28l,
3 Fair Valuation of for Financial Assets 3 (3,125.96)
4 Defered Tax (131.30)
Sub Total t,Los.7t

Net profit/ Reserves as per Ind As (328.20) (1,031.02) (1,632.04) (372.261

Notes:

1 Fair valution as deemed cost for Propertv, plant and Eouipment


Considered fair value for propefi, viz land admeasuring 110.7 acres, situated in Andhra pradesh in India, with
impact of Rs.4743.25 lakhs in accordance with stipulations of IND AS L01 (see IND AS i.6) with the resultant
impact being accounted for in the reserves.

2 Fair Valuation of Intangible Assets


Considered fair value of Intangible Assets based on expected future economic benefits using reasonable and
supportable assumptions in accordance with stipulations of IND AS 38 with the resultant impact being
accounted for in the reserves.

3 Fair valuation for Financial Assets


The Company has valued financial assets at fair value. lmpact of fair value changes as on the date of transition,
is recognised in opening reserves and changes thereafter are recongnised in Profit and Loss Account or Other
Comprehensive Income, as the case may be.

4 Defered Tax
The lmpact of transition adjustments together with IND AS mandate of using balance sheet approach (against
profit and loss approach in the previous GMP) for computation of deferred taxes has resulted in charge to the
Reserves, on the date of transition, with consequential impact to the Profit and Loss account for the subsequent
periods.

5 The Audit Committee has reviewed the above results and the Board of Directors has approved the above results

and its release at their resepective meetings held on 09th February, 2017. The Statutory Auditors of
Company have carried out a Limited Review ofthe results for the current quarter.

Place: Hyderabad
Datei 09.02.2077
DIN: 01516152